跳到正文

LEIDEN JEFFREY M 内部人交易:近期 SEC Form 4 交易

过去 18 个月,LEIDEN JEFFREY M(CIK 1242825)在 2 家公司共报告 30 笔 SEC Form 4 内部人交易(最近一笔 2026-05-11)。

日期公司身份类型股数市值
2026-05-11Odyssey Therapeutics, Inc. (ODTX)董事买入5,000$100,000
2026-05-11Odyssey Therapeutics, Inc. (ODTX)董事买入28,698$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)董事买入2,963$0
2026-05-11Odyssey Therapeutics, Inc. (ODTX)董事卖出17$306
2026-02-26VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出3,547$1.7M
2026-02-19VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman买入8,269$0
2026-02-19VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出2,964$1.4M
2026-01-26VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman买入9,012$0
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出4,352$1.9M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出4,469$2.0M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出1,320$582,463
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出2,469$1.1M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman买入63,781$5.5M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出7,899$3.5M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出1,152$515,002
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出2,320$1.0M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出5,880$2.6M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出5,809$2.6M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出15,681$7.1M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出10,360$4.7M
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出2,070$942,305
2025-12-05VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman买入1$91
2025-11-17VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman买入19,688$1.8M
2025-11-17VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出18,528$8.2M
2025-11-17VERTEX PHARMACEUTICALS INC / MA (VRTX)Executive Chairman卖出1,160$511,618

来源:SEC Form 4 申报文件 · 截至 2026-05-11